1-832-868-1888
order@swbio.com
Catalog Number: |
48403 |
other_names: | B Lymphocyte Induced Maturation Protein 1 antibody Beta interferon gene positive regulatory domain I binding factor antibody Beta-interferon gene positive regulatory domain I-binding factor antibody BLIMP-1 antibody BLIMP1 antibody Positive Regulatory Domain I Binding Factor 1 antibody Positive regulatory domain I-binding factor 1 antibody PR Domain Containing 1 antibody PR domain containing 1 with ZNF domain antibody PR domain containing 1 with ZNF domain isoform 2 antibody PR domain containing protein 1 antibody PR domain zinc finger protein 1 antibody PR domain-containing protein 1 antibody PRDI BF1 antibody PRDI binding factor 1 antibody PRDI-BF1 antibody PRDI-binding factor 1 antibody PRDM 1 antibody Prdm1 antibody PRDM1_HUMAN antibody |
Amount: |
100μg |
calculated_mw: | 92 kDa |
host_species: | Mouse |
Price: |
$529 |
Swiss-Prot No: |
Swiss-Prot#:O75626 |
Form of Antibody: |
1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
Storage/Stability: |
|
Immunogen: |
Recombinant protein |
Purification: |
ProA affinity purified |
Specificity/Sensitivity: |
|
Applications: |
WB, ICC, FC |
Background: |
The development and differentiation of plasma cells, which are terminally differentiated B-cells, are induced by Blimp-1 (B lymphocyte-induced maturation protein, also designated PRDI-BF1). Blimp-1 is a transcriptional repressor that localizes to the nucleus and is considered a master regulator of terminal B-cell development. Alone, Blimp-1 is sufficient to trigger terminal B-cell differentiation. Blimp-1 upregulates the expression of syndecan-1 and J chain, represses IFN-b gene transcription and associates with HDAC to recruit it to DNA, thereby repressing c-myc. Blimp-1 is expressed during the late stages of B-cell differentiation in immunoglobulin-secreting plasma cells, as well as in long-lived, bone marrow plasma cells. The expression of Blimp-1 defines a checkpoint beyond which fully activated B cells proceed to the plasma cell stage, whereas immature and partially activated cells are eliminated. |
References: |
|
appl_detail: |
WB: 1:500-1:2,000 |
QUICK LINKS
Unique Antibodies Cancer/Apoptosis antibody Tag Antibody Neuroscience antibody MAP kinase antibody Secondary AntibodyCONTACT US
1-832-868-1888 order@swbio.comGET IN TOUCH